Web8 de jul. de 2024 · Currently, the standard induction of primary central nervous system lymphoma (PCNSL) is high-dose methotrexate (HD-MTX)-based chemotherapy [1, 2].Addition of high-dose cytarabine (HD-Ara-C) to HD-MTX 3.5 g/m 2 followed by whole-brain radiotherapy (WBRT) led to a significantly higher complete response rate (46% vs … WebThirty-two patients with untreated ALL (n = 26) or lymphoblastic lymphoma (n = 6) between 17 and 65 years of age were treated with a short remission induction course with VP16 …
Effect of dose on the pharmacokinetic and pharmacodynamic effects of ...
Web20 de jan. de 2024 · Since a high dose (2,000–3,000 mg/m 2 every 12 hours for 3 days or more) of Ara-C may increase the risk of induced toxicity or even early death, we did not … Web25 de mai. de 2024 · Correspondence: Han W Tun, Mayo Clinic Florida Division of Hematology/Oncology, 4500 San Pablo Road S, Jacksonville, FL, 32224, USA, Tel +1 904-953-2000, Email [email protected]. Abstract: Intravascular large B cell lymphoma (IVL) is a rare subtype of diffuse large B cell lymphoma confined to small blood vessels with a … how expensive is carpet
MaxiCHOP / High Dose Ara-C + Rituximab
WebDose-related effects of ara-C include overcoming a relative transport impediment in human leukemia cells. This result then allows intracellular metabolism and incorporation into … WebCytosine Arabinoside. Cytosine arabinoside (Ara-C or cytarabine) is used for hematological malignancies, breast cancer, and occasionally is given intrathecally for leptomeningeal carcinomatosis. High-dose Ara-C causes a reversible cerebellar syndrome in 10% to 20% of patients. It usually starts a few days after treatment, peaks at 2 to 3 days ... Web1 de dez. de 1992 · To evaluate the long-term effects of high-dose cytarabine consolidation, we analyzed the results of 123 consecutive patients receiving high-dose cytarabine-anthracycline consolidation chemotherapy without maintenance therapy on one of two clinical trials conducted from 1982 to 1991, and examined the effect of major … hidemyass trial